Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger ​with special purpose acquisition company Amanat Acquisition ‌Corp, the companies announced on Monday.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in